Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lung Neoplasms × Remifentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Neoplasms 3 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Myofibroma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hematologic Diseases 1 Endobronchial Metastases 1 Encephalocele 1 Ear Neoplasms 1 Cholecystitis 1 Breast Neoplasms 1 Brain Injuries 1

Interventions

Carboplatin 295 Cisplatin 218 Radiotherapy 177 Paclitaxel 174 Pemetrexed 165 Docetaxel 156 Gemcitabine 139 pembrolizumab 126 Erlotinib Hydrochloride 98 Etoposide 89 Magnetic Resonance Spectroscopy 83 Bevacizumab 75 Specimen Handling 67 durvalumab 64 Radiosurgery 63 Nivolumab 63 Vinorelbine 50 Drug Therapy 46 osimertinib 45 Gefitinib 42 Irinotecan 37 Biopsy 36 Topotecan 35 Radiation 35 Cyclophosphamide 35 atezolizumab 34 Standard of Care 33 Cetuximab 31 Blood Specimen Collection 30 Immunoglobulin G 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01381627 2013-02-28

EBUSed

Maisonneuve-Rosemont Hospital

Phase 4 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡